Alternatives to Rx.com

The only program here that bills insurance, which changes the arithmetic more than any discount on this page. The visit is covered in network or $250 self-pay, and the medication is billed separately from $164 per four-week supply — both figures published. It's built for perimenopause, not the postpartum year.

• $11/mo cheaper than Rx.com
• serves all 50 states, where Rx.com lists 49 states — all except Alaska, per its own FAQ
• offers FDA-approved brand pens, not just compounded

The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.

• serves all 50 states, where Rx.com lists 49 states — all except Alaska, per its own FAQ
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.

• serves all 50 states, where Rx.com lists 49 states — all except Alaska, per its own FAQ
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

A science-forward compounded shop with a broad peptide catalog and flat dosing — $170/mo semaglutide, $210/mo tirzepatide ongoing — but the homepage 'as low as' price is a promotional rate, and there's no postpartum or PCOS-specific content.

• $5/mo cheaper than Rx.com
• serves all 50 states, where Rx.com lists 49 states — all except Alaska, per its own FAQ
• has an oral option if you would rather not inject

A clean, all-50-states compounded option with named pharmacies, no membership and the consult included — reasonable and transparent on price, though it's a newer platform with thin public detail beyond the $199 headline.

• serves all 50 states, where Rx.com lists 49 states — all except Alaska, per its own FAQ
• has an oral option if you would rather not inject
• scores 78/100 against Rx.com's 57

⛔ FDA warning letter #728291 (Jun. 2026), which names orderlymeds.com. One of the few sites in this round to publish real cash prices for both compounded ($149/mo semaglutide, $299/mo tirzepatide) and FDA-approved brand-name options (Wegovy® $1,839/mo, Zepbound® $1,498/mo) — a named Chief Medical Officer, licensed in all 50 states, though no content addresses postpartum or PCOS.

• $26/mo cheaper than Rx.com
• serves all 50 states, where Rx.com lists 49 states — all except Alaska, per its own FAQ
• offers FDA-approved brand pens, not just compounded

About as much as anyone in this category tells you: four formats with full plan tables, and both the pharmacy and the prescribing physician named with addresses. Nothing here addresses nursing, postpartum timing or PCOS.

• $26/mo cheaper than Rx.com
• serves all 50 states, where Rx.com lists 49 states — all except Alaska, per its own FAQ
• has an oral option if you would rather not inject

Both molecules have confirmed, tiered pricing, which appears only inside the signup flow — the public site carries no price at all — with a real gotcha: the 3-month plan costs more per month than month-to-month.

• serves all 50 states, where Rx.com lists 49 states — all except Alaska, per its own FAQ
• offers FDA-approved brand pens, not just compounded
• scores 71/100 against Rx.com's 57

A genuinely transparent tiered-pricing shop — as low as $149/mo semaglutide or $199/mo tirzepatide on the annual plan — with press mentions and bilingual support, though no postpartum or PCOS-specific content.

• $26/mo cheaper than Rx.com
• serves all 50 states, where Rx.com lists 49 states — all except Alaska, per its own FAQ
• has an oral option if you would rather not inject